Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA.
Bioorg Med Chem Lett. 2012 Apr 1;22(7):2609-12. doi: 10.1016/j.bmcl.2012.01.110. Epub 2012 Feb 9.
Pyridyl aminothiazoles comprise a novel class of ATP-competitive Chk1 inhibitors with excellent inhibitory potential. Modification of the core with ethylenediamine amides provides compounds with low picomolar potency and very high residence times. Investigation of binding parameters of such compounds using X-ray crystallography and molecular dynamics simulations revealed multiple hydrogen bonds to the enzyme backbone as well as stabilization of the conserved water molecules network in the hydrophobic binding region.
吡啶基氨基噻唑是一类新型的 ATP 竞争性 Chk1 抑制剂,具有优异的抑制潜力。通过在核心结构上修饰乙二胺酰胺,可以得到具有低皮摩尔效力和非常高的停留时间的化合物。使用 X 射线晶体学和分子动力学模拟研究这些化合物的结合参数表明,它们与酶骨架形成多个氢键,并稳定了疏水性结合区域中保守的水分子网络。